Rivera-Penera T, Gugig R, Davis J, et al
doi: 10.1016/0005-2728(87)90061-2
NSAIDs are a common cause of gastric ulcers and intestinal lesions due to their inhibition of prostaglandin synthesis, which is crucial for mucosal defense
Semaglutide (Wegovy) lowers heart attack, stroke, and cardiovascular death risk by 20% in high-risk adults
Dual role of LC in human health, insights of beneficial short term usage and potentially harmful long term complications F/B: Firmicutes-to-Bacteroidetes
Learn More About Semaglutide What is Semaglutide Semaglutide is a GLP-1 (glucagon-like peptide-1) receptor agonist a synthetic analog of the naturally occurring incretin hormone GLP-1, engineered with a fatty acid side chain that extends its half-life to approximately one week, enabling once-weekly subcutaneous injection